Intratumoral administration of the Toll‐like receptor 7/8 agonist 3M‐052 enhances interferon‐driven tumor immunogenicity and suppresses metastatic spread in preclinical triple‐negative breast cancerDamien Zanker, Belinda S. Parker|Clinical & Translational Immunology|2020Cited by 37